Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240
- Authors
- Merle, P[Merle, P.]; Kulkarni, AS[Kulkarni, A. S.]; Ryoo, BY[Ryoo, B-Y.]; Cheng, AL[Cheng, A-L.]; Kudo, M[Kudo, M.]; Bouattour, M[Bouattour, M.]; Lim, HY[Lim, H. Y.]; Breder, V[Breder, V.]; Edeline, J[Edeline, J.]; Chao, Y[Chao, Y.]; Ogasawara, S[Ogasawara, S.]; Yau, T[Yau, T.]; Garrido, M[Garrido, M.]; Chan, S[Chan, S.]; Daniele, B[Daniele, B.]; Norquist, J[Norquist, J.]; Chen, E[Chen, E.]; Siegel, AB[Siegel, A. B.]; Zhu, AX[Zhu, A. X.]; Finn, RS[Finn, R. S.]
- Issue Date
- Oct-2019
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.30, pp.256 - 256
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 30
- Start Page
- 256
- End Page
- 256
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.